MedTrace Logo

Testing a Personalize Medication Log for Patients With Lymphoma

NCT02370446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional information is helpful and if having this additional information about their treatment schedule has an effect on their quality of life.

Conditions

Interventions

OTHER

personalized medication log

OTHER

standard of care

BEHAVIORAL

questionnaires

BEHAVIORAL

Cognitive Interview

Sponsors & Collaborators

Principal Investigators

  • Kimberly Anselmi, RN · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02370446 on ClinicalTrials.gov